R21 malaria vaccine is protective against intradermal but not intravenous Plasmodium falciparum sporozoites in a randomized controlled human malaria infection study in Kenyan adults

Melissa C Kapulu, Francesca Orenge, Domtila Kimani, Elizabeth Kibwana, Hillary Kibet, Mary Mutahi, Mehreen S Datoo, Duncan Bellamy, Janet Musembi, Omar Ngoto, Hamisi Rashid, Stellamaris Akinyi, Mwaganyuma H Mwatasa, Lydia Nyamako, Kelvias Keter, Rose Gatheru, Agnes Mutiso, Jennifer Musyoki, Jedidah Mwacharo, Yonas Abebe, Eric J James, Peter F Billingsley, Caroline Ngetsa, Moses Mosobo, Johnstone Makale, Brian Tawa, Kevin Wamae, Lynette I Ochola-Oyier, Juliana Wambua, Alison Lawrie, Fernando Ramos-Lopez, Rachel Roberts, Thomas L Richie, B. Kim Lee Sim, Stephen L Hoffman, Katie J Ewer, Adrian V S Hill, Mainga Hamaluba, Philip Bejon
doi: https://doi.org/10.1101/2024.08.06.24311495

Article Information

doi 
https://doi.org/10.1101/2024.08.06.24311495
History 
  • August 8, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Melissa C Kapulu1,4,*,
  2. Francesca Orenge1,
  3. Domtila Kimani1,
  4. Elizabeth Kibwana1,
  5. Hillary Kibet1,
  6. Mary Mutahi1,
  7. Mehreen S Datoo2,
  8. Duncan Bellamy2,
  9. Janet Musembi1,
  10. Omar Ngoto1,
  11. Hamisi Rashid1,
  12. Stellamaris Akinyi1,
  13. Mwaganyuma H Mwatasa1,
  14. Lydia Nyamako1,
  15. Kelvias Keter1,
  16. Rose Gatheru1,
  17. Agnes Mutiso1,
  18. Jennifer Musyoki1,
  19. Jedidah Mwacharo1,
  20. Yonas Abebe3,
  21. Eric J James3,
  22. Peter F Billingsley3,
  23. Caroline Ngetsa1,
  24. Moses Mosobo1,
  25. Johnstone Makale1,
  26. Brian Tawa1,
  27. Kevin Wamae1,
  28. Lynette I Ochola-Oyier1,
  29. Juliana Wambua1,
  30. Alison Lawrie2,
  31. Fernando Ramos-Lopez2,
  32. Rachel Roberts2,
  33. Thomas L Richie3,
  34. B. Kim Lee Sim3,
  35. Stephen L Hoffman3,
  36. Katie J Ewer2,
  37. Adrian V S Hill2,
  38. Mainga Hamaluba1 and
  39. Philip Bejon1,4
  1. 1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  2. 2Jenner Institute, University of Oxford, United Kingdom
  3. 3Sanaria Inc., Rockville, MD, USA
  4. 4Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University Oxford, Oxford, United Kingdom
  1. ↵*Corresponding author: mkapulu{at}kemri-wellcome.org
Back to top
Posted August 08, 2024.
Download PDF

Supplementary Material

Data/Code
Email
R21 malaria vaccine is protective against intradermal but not intravenous Plasmodium falciparum sporozoites in a randomized controlled human malaria infection study in Kenyan adults
Melissa C Kapulu, Francesca Orenge, Domtila Kimani, Elizabeth Kibwana, Hillary Kibet, Mary Mutahi, Mehreen S Datoo, Duncan Bellamy, Janet Musembi, Omar Ngoto, Hamisi Rashid, Stellamaris Akinyi, Mwaganyuma H Mwatasa, Lydia Nyamako, Kelvias Keter, Rose Gatheru, Agnes Mutiso, Jennifer Musyoki, Jedidah Mwacharo, Yonas Abebe, Eric J James, Peter F Billingsley, Caroline Ngetsa, Moses Mosobo, Johnstone Makale, Brian Tawa, Kevin Wamae, Lynette I Ochola-Oyier, Juliana Wambua, Alison Lawrie, Fernando Ramos-Lopez, Rachel Roberts, Thomas L Richie, B. Kim Lee Sim, Stephen L Hoffman, Katie J Ewer, Adrian V S Hill, Mainga Hamaluba, Philip Bejon
medRxiv 2024.08.06.24311495; doi: https://doi.org/10.1101/2024.08.06.24311495
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area